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Abstract 
Aim. To assess the anti-inflammatory effect associated to individual probiotic suspensions of 
riboflavin-producing lactic acid bacteria (LAB) in a colitis murine model. 
Methods and Results. Mice intrarectally inoculated with trinitrobenzene sulfonic acid 
(TNBS) were orally administered with individual suspensions of riboflavin-producing strains: 
Lactobacillus (Lact.) plantarum CRL2130, Lact. paracasei CRL76, Lact. bulgaricus CRL871, 
Streptococcus thermophilus CRL803; a non riboflavin-producing strain or commercial 
riboflavin. The extent of colonic damage and inflammation and microbial translocation to 
liver were evaluated. iNOs enzyme was analyzed in the intestinal tissues and cytokine 
concentrations in the intestinal fluids. Animals given either one of the four riboflavin-
producing strains showed lower macroscopic and histologic damage scores, lower microbial 
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decreased pro-inflammatory cytokines, compared to mice without treatment. The 
administration of pure riboflavin showed similar benefits. Lact. paracasei CRL76 
accompanied its anti-inflammatory effect with increased IL-10 levels demonstrating other 
beneficial properties in addition to the vitamin production.  
Conclusion. Administration of riboflavin-producing strains prevented the intestinal damage 
induced by TNBS in mice. 
Significance and impact of the study. Riboflavin-producing phenotype in LAB represents a 
potent tool to select them for preventing/ treating IBD.  
 
Keywords: riboflavin, colitis, lactic acid bacteria, probiotic, anti-inflammatory effect 
 
Introduction 
Inflammatory bowel diseases (IBD) are a group of chronic disorders characterized by 
inflammation of the gastrointestinal tract. Crohn's disease (CD) and ulcerative colitis (UC), 
the two main manifestations of IBD, exhibit common and distinct clinical and pathological 
characteristics (Espaillat et al. 2016). The pathogenesis of IBD is still unclear but they are 
defined as multifactorial diseases with genetic, immunological, environmental and microbial 
factors related to their development (Siczek et al. 2016). IBD have become global diseases 
with high incidence rates that affect the quality of life of patients and also increase their risk 
of colon cancer development (Chen et al. 2016). Current therapies for against IBD are 
limited by high costs, high toxicities and undesirable side effects (de Souza Araújo et al. 
2016; Wang et al. 2017). This emphasizes the need to search for novel therapeutic options. 
 
Accumulated data indicate that probiotic supplementation promotes beneficial effects in 
intestinal diseases such as IBD (LeBlanc and De Moreno de LeBlanc 2016). Probiotics are 
defined as “live microorganisms, which when administered in adequate amounts confer a 
beneficial health effect on the host” (FAO/WHO, 2001) (FAO/WHO 2001). Among probiotics, 
certain strains of lactic acid bacteria (LAB) have been shown to exert beneficial effects 
against IBD via different mechanisms, including the modulation of the intestinal microbiota 
and the alteration of their metabolic properties (de Moreno de LeBlanc and LeBlanc 2014), 
the reduction of oxidative stress (del Carmen et al. 2014) and the improvement of the host’s 
immune response (Ferreira dos Santos et al. 2016). In addition, some LAB have also been 
reported to have the capacity to produce antioxidant vitamins such as riboflavin (vitamin 
B2) (Burgess et al. 2006; LeBlanc et al. 2011b; Capozzi et al. 2012). Recently, our group 
demonstrated the anti-inflammatory effect of soymilk fermented by the riboflavin-
producing strain Lactobacillus (Lact.) plantarum CRL2130 in a murine model of colitis (Levit 
et al. 2017). The comparison with a related strain without the capacity to produce vitamin 
B2 and also with the supplementation of commercial vitamin allowed demonstrating that in 
addition of the mechanisms mentioned above, the bioproduction of certain vitamins such as 
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In the present study we evaluated the anti-inflammatory effect associated to the 
administration of riboflavin-producing LAB as individual probiotic suspensions (not in a food 
matrix). Therefore, the aim of this work was to assess i) the anti-inflammatory effect 
associated to individual probiotic suspensions and ii) the species/strain dependent character 
of this anti-inflammatory effect using a colitis murine model. 
 
Methods 
Bacterial strains and growth conditions 
Five strains of LAB belonging to the Culture collection of CERELA (Centro de Referencia para 
Lactobacilos, CONICET, San Miguel de Tucumán, Argentina) were used in this study. Four 
strains used were selected due to their riboflavin-producing capabilities as shown in 
previous studies (Juarez del Valle et al. 2014): Lac. plantarum CRL2130, Lact. paracasei 
CRL76, Lact. delbrueckii subsp. bulgaricus CRL871, Streptococcus (Strep.) thermophilus 
CRL803. Lact. plantarum CRL2130 is a riboflavin over-producing strain selected after 
exposure to increasing concentrations of roseoflavin, a structural analog of riboflavin. Lact. 
plantarum CRL691 was used as a non-riboflavin producing strain (negative control). Bacteria 
were grown for 16 h at 37ºC without agitation in 5 ml of Man, Rogose Sharpe (MRS,  
Britania, Buenos Aires, Argentina) for lactobacilli or LAPTg  containing (w/v) 1,5% peptone, 
1% tryptone, 1% yeast extract, 1% glucose and 0,1% Tween 80 for streptococci.  
After activation, riboflavin-producing LAB were used to inoculate at 4% (v/v) 10 mL of 
riboflavin-free culture medium (Riboflavin Assay Medium, Difco, Becton, Dickinson, and Co., 
Sparks, Maryland) and then incubated without agitation at 37ºC for 16 h.  
 
Preparation of probiotic suspensions and vitamin B2 solution 
After growth in the riboflavin-free culture medium or MRS (for Lact. plantarum CRL691), 
LAB cultures were washed with sterile saline solution (0,85% m/v NaCl) and resuspended in 
1 ml of this solution with the aim of concentrating 10 times. The final concentrations of 
bacteria for animal feeding were 5 ± 3 x 108 colony forming units per ml and 100µl were 
given to each mouse on a daily basis as described below.  
A pure riboflavin solution (40 g ml-1) was also prepared to administer to the animals as a 
control. Considering that Lact. plantarum CRL2130 is the strain under study that produces 
the highest concentration of riboflavin (capable of producing 1.6 g ml-1 of this vitamin in 
soymilk (Juarez del Valle et al. 2014)) and taking into account that the anti-inflammatory 
effect of the fermented beverage was observed when the mice consumed 3 ml per day 
(Levit et al. 2017), the mice in the present study require to consume approximately 4 g of 
this vitamin per day to have a comparable amount of riboflavin than those that consume 
the highest producing strain. 
 
Animals 
Female BALB/c mice (six week, n =52) were obtained from the inbred closed colony 
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Protection Committee of CERELA (CRL-BIOT-LT-2010/1A) and all experiments comply with 
the current laws of Argentina and international organizations for the use of experimental 
animals. The room was at 18-20 °C and 20% humidity under a 12 h light/dark cycle. The 
animals were fed with commercial riboflavin-free diet (Dyets, USA) (to avoid the 
interference of riboflavin from balanced rodent diets) and water ad libitum throughout the 
study. 
 
Induction of colitis and treatments 
Acute colitis was induced in mice by intrarectal injection of trinitrobenzene sulfonic acid 
(TNBS, Sigma, St. Louis, MO) as has been described previously (Levit et al. 2017). The control 
group (mock group) was treated with ethanol-PBS mixture instead of TNBS.  
Mice were divided into eight groups. Animals were orally administered with 100 l of saline 
solution (mock and TNBS + Saline groups), individual suspension of one of the riboflavin-
producing strains (TNBS + CRL2130, TNBS + CRL76, TNBS + CRL871 and TNBS + CRL803 
groups), the  non riboflavin-producing strain  (TNBS + CRL691 group) or riboflavin solution 
(TNBS + B2 group) using a gavage syringe once a day during five days. Figure 1 shows a 
scheme of experimental protocol with the samples obtained for the different assays. 
 
Macroscopic and histological evaluation of colon damage 
Evaluation of macroscopic damage in colon was performed according to previously 
established scoring system on a 0-9 scale, by two independent observers. In this system, the 
presence of each parameter (erythema, hemorrhage, edema, stricture formation, 
ulceration, fecal blood, presence of mucus, diarrhea and adhesions) adds one point (Cenac 
et al. 2002).  
Fixed colons were embedded in paraffin; 5-μm paraffin sections were cut, stained with 
hematoxylin and eosin (H&E) and observed under a light microscopy for histological 
examination, or used for immunofluorescence analysis. The histologic damage (Table 1) was 
evaluated using a histopathological score described previously (Ameho et al. 1997).  
 
Bacterial translocation to liver 
Livers were homogenized in peptone solution and serial dilutions of the homogenates were 
plated in triplicate into the following media: MRS agar, MacConkey agar (both from Britania, 
Buenos Aires, Argentina) and LAPTg agar (1% glucose, 1.5% peptone, 1% tryptone, 1% yeast 
extract and 0.1% Tween 80). The plates were incubated at 37ºC and the number of bacterial 
colonies was recorded after 48 - 72 h. 
 
Measurment of iNOs (inducible Nitric Oxyde Synthase) producing cells 
The number of iNOs+ cells was determined by indirect immunofluorescence on large 
intestine tissue slides following the technique describe previously (de Moreno de LeBlanc et 
al. 2004).  Rabbit anti-iNOs polyclonal antibody (Zymed Laboratories Inc., San Francisco, 
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with FITC (Jackson Immuno Research, Labs. Inc., West Grove USA) as secondary. Fluorescent 
cells were counted by two different scientists in thirty fields of vision at 1000x of 
magnification using a fluorescence light microscope. The results were expressed as the 
number of positive cells in ten fields of vision. The group of mice that received the non 
riboflavin- producing strain was not included because significant differences with the 
inflamed control were not observed when the other parameters of inflammation were 
analysed. 
 
Determination of cytokines in the intestinal contents 
Luminal contents of colons were centrifuged (3000 xg, 10 min, 4ºC), and the supernatants 
were stored at -80º C until cytokines determinations. Cytometric Bead Array (CBA) mouse 
inflammation kit (BD Bioscience, San Diego, CA, USA) was used to measure Interleukin-10 
(IL-10), IL-17, Tumor Necrosis Factor (TNF-α), Interferon γ (IFN-γ), IL-6, IL-4 and IL-2 levels, 
following the manufacturer's instructions. Results were expressed as pg of cytokine per mg 
of protein in the colon contents. The group of mice that received the non riboflavin- 
producing strain was not included in this determination because the same reason explained 
for iNOS+ cells determination. 
 
Statistical analysis 
Statistical analyses were performed by MINITAB 15 software (Minitab, State College, PA, 
USA) using ANOVA general linear model, followed by Tukey’s post hoc test and p < 0.05 was 




Macroscopic and histologic evaluation of colons 
The intrarectal injection of TNBS caused severe intestinal inflammation in mice 
characterized by high values of macroscopic and histological damage scores in the large 
intestines (Fig. 2a). Macroscopically, most of mice from TNBS + Saline group showed 
erythema, hemorrhage, ulcerations, fecal blood and adhesions. Similar damages have been 
observed in mice that received Lact. plantarum CRL691. The administration of riboflavin-
producing bacteria or the commercial vitamin reduced the macroscopic damages where 
only some mice showed ulceration, presence of mucus and / or diarrhea and most had 
intestines similar to the mock group (Fig. 2b). The results of H&E staining (Fig. 2c) showed 
prominent inflammatory cell infiltration in the mucosa and submucosa, crypt lesions, and 
loss of the goblet cells in animals from TNBS + Saline and TNBS + CRL691 groups, compared 
to the colons of animals from mock group. The severity of inflammation was significantly 
lower (p < 0.05) in most of the riboflavin-producing bacteria administered groups (TNBS + 
CRL2130, TNBS + CRL76, TNBS + CRL871 groups) compared to TNBS + Saline group. Most of 
mice presented inflammatory infiltrate (admixture of neutrophils) in mucosal and / or 
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showed prominent infiltrates (with predominance of neutrophils) involving deeper areas. 
The administration of commercial riboflavin showed beneficial effects similar to those 
observed with the vitamin producing bacteria.  
 
Bacterial translocation 
The intestinal damage observed in the macroscopic and histological analysis was confirmed 
with the microbial translocation assay. As shown in Fig. 3, compared with the mock group, 
the microbial counts in liver were significantly (p < 0.05) higher in TNBS + Saline group. Mice 
given the non-riboflavin producing strain (TNBS + CRL691 group) did not show significantly 
different microbial counts compared to the TNBS + Saline group. The presence of 
microorganisms in the liver of mice from mock group is attributed to the slight inflammation 
caused by the ethanol; so these values have been taken as a baseline for the comparisons 
with the other groups. The number of colony forming units was reduced significantly (p < 
0.05) when the mice received either one of the four riboflavin-producing strains (TNBS + 
CRL2130, TNBS + CRL76, TNBS + CRL871 and TNBS + CRL803 groups) as well as in those 
animals that received the commercial vitamin (TNBS + B2 group), compared to TNBS + Saline 
group.  
 
iNOs+ cells in the large intestinal tissues 
The evaluation of the iNOS+ cells in the colon tissues were performed in the groups that 
received the riboflavin-producing strains in comparison with the mock group and with the 
mice from TNBS + Saline and TNBS + B2 groups. As shown in Fig. 4, it was found that TNBS 
inoculation resulted in significantly (p < 0.05) elevated number of iNOs+ cells in intestinal 
tissues of mice from TNBS + Saline group compared to mock group. Furthermore, values of 
iNOs+ cells were significantly (p < 0.05) lower in the intestines of animals that received 
treatment with the riboflavin-producing strains (TNBS + CRL2130, TNBS + CRL76, TNBS + 
CRL871 and TNBS + CRL803 groups) in relation with TNBS + Saline group. For commercial 
riboflavin treated mice (TNBS + B2 group) similar values for iNOs+ cells as when the bacteria 
were administered were observed in the intestinal tissues. The group given the riboflavin 
over-producing strain (TNBS + CRL2130) was the only one that reached values similar to 
mock group (p > 0.05).  
 
Cytokine levels in intestinal fluids  
The assessment of the cytokines concentrations was performed in the same groups detailed 
for iNOS evaluation. As depicted in Fig. 5, TNBS instillation leads the mice from TNBS + 
Saline group to significantly increase (p < 0.05) the levels of pro-inflammatory cytokines 
TNF-α, IL-17, IFN-γ and IL-6 in the intestinal fluids compared with the mock group. The anti-
inflammatory cytokine IL-10 was maintained with similar values in both TNBS + Saline and 
mock groups. In contrast, a significant (p < 0.05) decrease was observed in the levels of pro-
inflammatory cytokines in the intestinal contents of TNBS + CRL2130, TNBS + CRL871 and 
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showed significant decreased levels only for some pro-inflammatory cytokines. Mice from 
TNBS + CRL76 group showed an increase for IL-10 concentrations compared to the other 
test groups, accompanied by decreased levels of pro-inflammatory cytokines, compared to 
TNBS + Saline group. 
 
Discussion 
Pathogenesis of IBD is not yet fully understood; however,  several studies have 
demonstrated that increased production of inflammatory mediators including eicosanoids, 
cytokines, chemokines and reactive oxygen species (ROS) are implicated in this process  (de 
Souza Araújo et al. 2016). The overproduction of ROS  can lead to an imbalance among 
these oxidant molecules and the antioxidant defense system, predisposing the patients to 
intestinal tissue destruction and the development of IBD (Ji et al. 2015). So, anti-oxidant 
agents, such as some vitamins,  have been associated to beneficial effects against IBD, both 
in animal models and in human reports (Moura et al. 2015) (Selhub et al. 2013). 
 
The use of probiotic microorganisms have been proposed as an alternative for IBD patients 
due to numerous beneficial effects, including but not limited to the modulation of the 
immune system and the restoration of intestinal microbial balance. Probiotic LAB strains 
expressing high levels of antioxidant enzymes have been explored as a tool to combat 
oxidative stress, giving rise to potential applications for IBD treatment (LeBlanc et al. 2011a). 
It was also demonstrated that Strep. thermophilus CRL807 with intrinsic immunomodulatory 
properties and genetically engineering to express antioxidant enzymes (CAT and SOD), 
enhanced its anti-inflammatory activity and diminished the severity of inflammation in a 
mouse model of colitis (del Carmen et al. 2014). 
 
In addition to above mentioned mechanisms, certain strains of LAB have also been shown to 
have the capacity to produce antioxidant vitamins such as riboflavin. The antioxidant nature 
of riboflavin, both by itself and as part of the glutathione reductase and xhantine oxidase 
systems is well known. Studies confirmed the role of this vitamin in protecting the body 
against oxidative stress (Thakur et al. 2016). Recently, our group has reported the anti-
inflammatory potential of soymilk fermented by the riboflavin overproducing Lact. 
plantarum CRL2130 in a TNBS- induced colitis mice model (Levit et al. 2017). This was the 
first study demonstrating the beneficial effect of a riboflavin-producing strain in an 
intestinal inflammation animal model. At difference, the parenteral related strain (the same 
evaluated in the present work), without the capacity to produce the vitamin did not show 
benefits in the inflamed mice. In function of these results, the aim of the present work was 
to improve the proposal of riboflavin- overproducing phenotype as a possible part of the 
probiotic phenotype of LAB selected for their anti-inflammatory / anti-oxidant properties  
(Parvez et al. 2006; Sleator and Hill 2008; Arena et al. 2014).The use of bacterial suspensions 
instead of a fermented food for the protocol of riboflavin-producing bacteria administration 
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IBD. The assays demonstrated that all the riboflavin-producing strains tested in the IBD 
model decreased the severity of inflammation with lower macroscopic and histologic 
intestinal damage scores, and a decrease in bacterial translocation to liver compared to 
TNBS control group. The anti-inflammatory effect obtained when the riboflavin-producing 
Lact. plantarum CRL2130 was administered in a food matrix was maintained with the 
protocol of administration used in the present work (Levit et al. 2017). Alleviation of 
inflammation has also been noted by reduced levels of pro- inflammatory cytokines in the 
intestinal fluids from mice that received either one of the four riboflavin producing strains, 
similar to the effect observed when the commercial riboflavin was administered. This effect 
was also associated to significant decrease of iNOS expression in the intestinal tissues, 
compared to inflamed control group, by being the lowest values (without significant 
differences with the mock group) observed in the mice that received the riboflavin 
overproducing strain (Lact. plantarum CRL2130). The pathological role of increased nitric 
oxide (NO) production and iNOS expression has been suggested in models of experimental 
colitis (Khelifi et al. 2017) and also by analyzing samples from humans suffering IBD (Guihot 
et al. 2000; Dhillon et al. 2014) since many years ago. The administration of Lact. paracasei 
CRL76 to mice was accompanied by an immunomodulatory effect evidenced by increased 
production of IL-10. For this strain, other mechanisms, in addition to riboflavin production, 
would be involved. These differences were also observed in vitro by analyzing the 
production of NO by LPS stimulated macrophages when they were co-cultured with the LAB. 
All riboflavin-producing LAB under study had an anti-inflammatory effect; however, Lact. 
paracasei CRL76 showed the lowest production of NO in this system, even lower than the 
commercial vitamin (data not shown). Our studies are supported by anti-inflammatory 
properties associated to riboflavin. It was previously reported that riboflavin treatment was 
capable to reduce TNF-α release from blood leukocytes in addition to improving levels of 
antioxidant parameters (reduced glutathione and malondialdehyde) in rats with CCl4-
induced hepatic injury (Al-Harbi et al. 2014). 
 
In agreement with our results another study has reported the beneficial effect of vitamin-
producing LAB (Lact. plantarum 156, Lact. brevis 165 and Lact. rhamnosus 195) isolated 
from fecal samples of healthy humans in Iran. These strains were identified as vitamin B12 
producers and additionally have showed an anti-inflammatory effect in a mouse colitis 
model (Rohani et al. 2015). 
 
Our data indicates that the administration of riboflavin-producing strains can prevent acute 
mice colitis induced by TNBS similar to the use of the commercial vitamin. The anti-
inflammatory effect observed could be attributed, at least partially, to the antioxidant 
actions of riboflavin, which alleviates chemically induced colitis in mice by ameliorating 
oxidative stress. However the antioxidant activity of the tested strains was not assayed 
indicating the need for further studies. In addition to vitamin production, other 
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potential to study this strain in other models associated to inflammation. It is also important 
to mention that the beneficial effect observed when riboflavin-producing LAB were 
administered as a bacterial suspension are in accordance with previous results obtained 
when the strains were given in a food matrix (soymilk), suggesting that they could be 
included in a pharmaceutical formulation. We also maintain the opportunity to test our 
hypothesis with a major number of strains or biofortified matrices described by other 
authors (Capozzi et al. 2011; Russo et al. 2014; Puertas et al. 2016; Chandrasekar Rajendran 
et al. 2017). 
 
In conclusion, the present work provides in vivo evidence that oral administration of 
riboflavin-producing LAB can prevent TNBS-induced colitis in mice similar to the use of the 
commercial pure vitamin, which indicates that this phenotype in probiotic LAB may 
represent a potent tool, as an alternative or as a complement to current therapies, for 
preventing and treating IBD.  
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Table 1. Histologic score of colon damage 
 
Microscopic findings                    Grade 
Intestinal histology identical to normal mice                        0 
Inflammatory infiltrate (admixture of neutrophils) in mild mucosal 
and/or submucosal and edema, punctuate mucosal erosions, muscularis 
mucosa intact 
                       1 
Grade 1 changes involving 50% of the sepcimen                        2 
Prominent inflammatory infiltrate and edema (predominance of 
neutrophils) with deeper areas of ulceration extending through the 
muscularis mucosae into the sub mucosa; inflammatory cells invading 
the muscularis propria but without muscle necrosis 
                      3 
Grade 3 changes involving 50% of the specimen                        4 
Extensive ulceration with coagulative necrosis that extends deep into 
the muscularis propria 
                       5 





Fig. 1. Schematic representation of the protocol used for the colitis model. Colitis was 
induced by intrarrectal administration of TNBS solution. One day before the TNBS instillation 
different individual LAB suspensions, commercial riboflavin or saline were intragastrically 
administrated to mice and this administration continued during four days more. On de fifth 
day of the experiment mice were euthanized, liver and large intestine were extracted to 
further analysis described in the scheme. 
 
 
Fig. 2.Effects of riboflavin-producing LAB on intestinal damages in mice with TNBS-induced 
colitis. Macroscopic (black bars) and microscopic (grey bars) damage score correspond to 
samples taken 5 days post TNBS (a). The results were obtained from two independent 
experiments with 7 mice per group (except for mock group n=3). For macroscopic 
observation the score correspond to the addition of each finding associated to the damage. 
For microscopic score, each value correspond to the grade of damage described in M&M. * 
p<0.05 compared with mock group; # p<0.05 compared with TNBS + Saline group. 
Representative photographs of large intestine for each group were selected (b). 
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Fig. 3.Effects of riboflavin-producing LAB on microbial translocation to liver in mice with 
TNBS-induced colitis. Microbial growth in MacConkey, MRS or LAPTg of liver samples 
obtained from different groups were evaluated: mock (black), TNBS+ Saline (white), TNBS+ 
CRL691 (light grey), TNBS+ CRL2130 (white with diagonal lines), TNBS+CRL76 (dark grey), 
TNBS+ CRL871 (dotted white), TNBS+ CRL803 (white with horizontal lines) and TNBS+ B2 
(dotted black). Values are represented as the mean (n=7, except for the mock group n=3) ± 
SD of the log CFU g-1 liver. # p<0.05 compared with TNBS + Saline group. 
 
Fig. 4.Effects of riboflavin-producing LAB on the number of iNOs+ cells in mice with TNBS-
induced colitis. The results are expressed as the mean of the number of iNOs positive cells 
counted in ten fields by two independent scientists at 1000x of magnification (a). The values 
are the means of 7 mice from each group ± SD (except for mock group that had 3 mice). 
Data with a different letter (a- d) statistically differ (p< 0.05). Mock (black), TNBS+ Saline 
(white),TNBS+ CRL2130 (white with diagonal lines), TNBS+CRL76 (dark grey), TNBS+ CRL871 
(dotted white), TNBS+ CRL803 (white  with horizontal lines) and TNBS+ B2 (dotted black). 
Representative images of immunofluorescence assay of large intestine slices for each group 
obtained with a magnification of 1000X are showed (b). 
 
Fig. 5.Effects of riboflavin-producing LAB on cytokine levels in intestinal fluids of mice with 
TNBS-induced colitis.The concentration (pg mg-1 protein) of IL-10 (black), IL-17 (white), TNF-
α (light grey), IFN-γ (white with diagonal lines), IL-6 (dark grey), IL-4 (dotted white) and IL-2 
(white with horizontal lines) were measured in the large intestine contents of mice from 
each group. Results are expressed as means (n=7, except for the mock group n=3) ± SD. For 
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